Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History StudyRachael F. Grace, Wilma Barcellini, Paola Bianchi et al.|Blood|2018Cited by 165
Safety and Efficacy of Mitapivat in Pyruvate Kinase DeficiencyRachael F. Grace, Bertil Glader, Christian Rosé et al.|New England Journal of Medicine|2019Cited by 162
Clinical utility of next‐generation sequencing in the diagnosis of hereditary haemolytic anaemiasArchana M. Agarwal, Robert D. Christensen, Roberto Nussenzveig et al.|British Journal of Haematology|2016Cited by 98
Genotype‐phenotype correlation and molecular heterogeneity in pyruvate kinase deficiencyPaola Bianchi, Rachael F. Grace, Elisa Fermo et al.|American Journal of Hematology|2020Cited by 66
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History StudyEduard J. van Beers, Rachael F. Grace, Stephanie van Straaten et al.|Haematologica|2018Cited by 61